ICU Medical Inc (ICUI) Stock Forecast & Price Target
ICU Medical Inc · NASDAQ
$165.84+4.38 (+2.71%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering ICU Medical Inc, 5 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $163.00 to $182.00, so the covering firms are broadly aligned. The average target of $172.00 sits 4% above the current $165.84. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.08 next quarter toward $9.34 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy120%
Buy480%
Hold00%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to ICU Medical Inc.
As of Jul, 5 of 5 firms rate ICUI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ICUI EPS & revenue forecast
EPS · NEXT QUARTER
$2.08
Range $2.02 – $2.15 · 7 analysts · +3% YoY
Next period, 7 analysts expect ICU Medical Inc to earn $2.08 a share (range $2.02 – $2.15), versus $2.03 a year earlier. Full-year consensus is $8.16, growing to $9.34 the year after.
REVENUE · NEXT QUARTER
$551.8M
Range $535.7M – $558.0M · 7 analysts · +3% YoY
Revenue is expected to reach $551.8M (range $535.7M – $558.0M), +2.7% year-over-year. Full-year consensus is $2.2B, rising to $2.3B next year.
Top analysts covering ICU Medical Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ICUI.
#1
Mike Matson
Needham · Rank #204
Buy
$165.00-0.5% to target
Overall win rate
31%
+ Follow
#2
Jason Bednar
Piper Sandler · Rank #303
Buy
$163.00-1.7% to target
Overall win rate
33%
+ Follow
#3
Brett Fishbin
KeyBanc
Buy
$182.00+9.7% to target
Coverage
—
+ Follow
#4
JB
Jayson Bedford
Raymond James
Buy
$180.00+8.5% to target
Coverage
—
+ Follow
#5
MT
Michael Toomey
Jefferies
Buy
$200.00+20.6% to target
Coverage
—
+ Follow
ICUI stock forecast FAQ
What is ICUI's average 12-month price target?+
The 5 analysts with a live target average $172.00 for ICU Medical Inc over the next 12 months, ranging from a $182.00 high to a $163.00 low.
Is ICUI stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 5 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ICUI?+
The Street-high target is $182.00 (Keybanc), and the Street-low is $163.00 (Piper Sandler). The average of all 5 active targets is $172.00.
How many Wall Street analysts cover ICUI?+
5 analysts have an active rating on ICU Medical Inc, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering ICUI?+
Among analysts who currently cover ICUI, Mike Matson of Needham has the strongest overall Quantellect track record (Rank #204). Their current call is Buy with a $165.00 target.
What is ICU Medical Inc's projected EPS for next quarter?+
The consensus estimate is $2.08 per share (range $2.02 – $2.15) across 7 analysts. Full-year EPS is projected at $8.16, rising to $9.34 the following year.
How much revenue is ICU Medical Inc expected to report next quarter?+
Consensus revenue is $551.8M (range $535.7M – $558.0M). Full-year revenue is projected at $2.2B, growing to $2.3B next year.
Have analysts been upgrading or downgrading ICUI lately?+
As of Jul, 5 of 5 firms rate ICUI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ICUI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
